Lantheus Holdings, Inc. Contract with Customer, Refund Liability
Lantheus Holdings, Inc. (LNTH) had Contract with Customer, Refund Liability of $4.65 million as of 2018-12-31, per its 10-K filed 2019-02-20.
Discontinued › Notes
us-gaap:ContractWithCustomerRefundLiability · last filed 2019-02-20
- 2018-12-31: Contract with Customer, Refund Liability $4.65M.
- 2018-09-30: Contract with Customer, Refund Liability $4.29M.
- 2018-06-30: Contract with Customer, Refund Liability $3.90M.
- 2018-03-31: Contract with Customer, Refund Liability $2.99M.
| Period end | Contract with Customer, Refund Liability |
|---|---|
| 2018-12-31 | $4.65M 10-K · filed 2019-02-20 |
| 2018-09-30 | $4.29M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $3.90M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $2.99M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $2.86M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |